| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |